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Abstract

Background: There has been an increased trend towards the legalisation of medicinal and recreational
cannabis use worldwide. This has been controversial as the long-term effects of frequent cannabis use on the
brain are still poorly understood. Methods: In this study, we investigated whether the legal stat of cannabis in
the United States of America (USA) is associated with problematic cannabis use and impulsivity in 329
frequent cannabis users. The data were collected in 2015 and were analysed in 2017. Ethical approval for this
study was obtained from Monash University in 2015. Results: The results indicated that participants'
problematic cannabis use and impulsivity was not different whether they resided in states where cannabis is
legal for medical and/or recreational use or prohibited. Limitations: The present study is a cross-sectional
design, making it difficult to infer causality and establish whether cannabis use is a cause, consequence, or
correlate of altered impulsivity. Conclusion: Our study supports the notion that frequent cannabis use is
associated with impulsive behaviours, whilst, conversely, we did not find an association between US state
legalisation and problematic cannabis use or impulsivity.
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Abstract
Background: There has been an increased trend towards
the legalisation of medicinal and recreational cannabis use
worldwide. This has been controversial as the long-term
effects of frequent cannabis use on the brain are still poorly
understood.
Methods: In this study, we investigated whether the legal status
of cannabis in the United States of America (USA) is associated
with problematic cannabis use and impulsivity in 329 frequent
cannabis users. The data were collected in 2015 and were
analysed in 2017. Ethical approval for this study was obtained
from Monash University in 2015.
Results: The results indicated that participants’ problematic
cannabis use and impulsivity was not different whether they
resided in states where cannabis is legal for medical and/or
recreational use or prohibited.

Introduction
Following the Single Convention on Narcotic Drugs in 1961,
recreational cannabis use was banned and its possession
became criminalised.1 Thereafter, cannabis-related crimes –
including use and possession – increased dramatically in
the USA and Europe, particularly amongst young people.1 A
decade later, concerns were raised regarding the detrimental
effects of criminal records on young people.2 Consequently,
some US states decriminalised cannabis use in the 1970s and
replaced imprisonment with fines.2 To date, across the USA,
cannabis has been legalised by 29 states for medical use and
8 states for both recreational and medical use. Yet, evidence
suggests an association between frequent cannabis use and
dependence, cognitive impairment, and vulnerability to
psychotic illness.3 Further evidence suggests that adolescent

Limitations: The present study is a cross-sectional design, making
it difficult to infer causality and establish whether cannabis use is a
cause, consequence, or correlate of altered impulsivity.
Conclusion: Our study supports the notion that frequent
cannabis use is associated with impulsive behaviours, whilst,
conversely, we did not find an association between US state
legalisation and problematic cannabis use or impulsivity.
Keywords: impulsivity, legal status of cannabis in the USA,
problematic cannabis use.
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cannabis users are at a greater risk for adverse outcomes,
including persistent cognitive impairment and increased risk
of psychotic symptoms.4 A primary public health concern has
been to establish whether the legalisation of cannabis is likely
to increase use amongst youth with concomitant negative
consequences. Studies show mixed results; some have found
higher rates of cannabis use in states that have legalised
medicinal use,5 whereas others have found no difference after
law enactment in the USA.6 MacCoun7 compared cannabis use
in the USA and Netherlands after the legalisation of cannabis
and found that cannabis use amongst students aged 15–16
years was higher in the USA. Other countries in the EU that
have not legalised cannabis either matched or exceeded the
rate of students’ cannabis use in the Netherlands.7 These
studies suggest that legalising cannabis for recreational and/
or medical purposes does not necessarily lead to an increase
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Figure 1. Legalisation status of cannabis use in the USA in 2015.

Cannabis is legal for recreational and/or medical use
Cannabis is prohibited

in cannabis use. Other studies show that cannabis use affects
regulatory networks of the brain and is associated with
impulsivity.8 For example, it was demonstrated that cannabis
increased impulsivity immediately after administration9;
changes in impulsivity due to cannabis consumption may
interfere with individuals’ self-regulation, leading to risky
or problematic behaviours.10 As the cannabis landscape
evolves and governments are increasingly turning towards
legalisation, the public health concerns around cannabis use
warrant further research. In the present study, we investigated
whether there was an association between legalisation status
and either problematic cannabis use or impulsivity in frequent
cannabis users and whether the legal status of cannabis in
the USA moderates the association between impulsivity and
problematic use.

Methods
Ethical approval for this study was obtained from Monash
University Human Research Ethics Committee (project number:
CF15/1235 – 2015000576). 329 frequent cannabis users were
recruited online via the Amazon Mechanical Turk (https://
www.mturk.com/) in 2015, and gave informed consent prior
to commencing the questionnaire. All participants were
US residents and frequent cannabis use was defined as
having used cannabis once or more per week for the past 12
months (mean consumption: 3.93, s.d.: 2.34 times per week).
Participants indicated that they had no history of diagnosed
alcohol or other illicit substance disorders and that they had
not used illicit substances other than cannabis once a month or
more across the past 12 months. The sample consisted of 196
males and 133 females. The majority were Caucasian (82%)
(see Table 1 for descriptive statistics.)

The Cannabis Use Problems Identification Test (CUPIT) was used
to assess problematic cannabis use. It is a 16-item self-report
scale with two subscales: ‘Impaired Control’ over cannabis use
and ‘Problems’ caused by or as a consequence of cannabis
use.11 About 95% of participants met criteria for being at risk
of developing a cannabis use disorder, as indicated by scores
above 12. About 73% of participants met criteria for cannabis
use disorder as indicated by scores above 20.11 The Barratt
Impulsiveness Scale was used to assess how often individuals
perform different behaviours. US state legalisation status was
obtained in 2015, and individuals were classified into two
groups: states where cannabis use was legal for recreational
and/or medical purposes (n=158) and states where cannabis
was prohibited (n=171) (see Figure 1).
The association between legalisation status and problematic
cannabis use (i.e. ‘Impaired Control’ and ‘Problems’) and
impulsivity were examined using a series of one-way analyses
of variance (ANOVA). To examine whether the relationship
between impulsivity and problematic cannabis use was
moderated by legalisation status, we used multiple regressions.
Problematic cannabis use was regressed on impulsivity,
legalisation status, the interaction between impulsivity and
legalisation status, and a vector of control variables (age, gender,
and ethnicity [defined by ‘Caucasian’ or ‘other’]). Statistical
analyses were performed using IBM SPSS Statistics version 23.

Results
A series of ANOVA found no association between state
legalisation status and CUPIT ‘Impaired Control’ subscale, CUPIT
‘Problems’ subscale, or impulsivity (see Figure 2). The three
ANOVA analyses were replicated using a subset of the sample
that comprised only the 73% of individuals who met criteria for a
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Demographic and clinical characteristics of participants.

Variable

Total (n=329)

Cannabis legal for medical
and/or recreational use
(n=158)

Cannabis is
prohibited (n=171)

Gender (%)

M: 196 (59.6%)
F: 133 (40.4%)

M: 101 (63.9%)
F: 57 (36.1%)

M: 95 (55.6%)
F: 76 (44.4%)

Age – Mean (SD)

M: 25.83 (3.27)
F: 26.12 (3.31)

25.67 (3.24)

26.20 (3.32)

Caucasian

n=270 (82.1%)

n=126 (79.7%)

n=144 (84.2%)

Other

n=59 (17.9%)

n=32 (20.3%)

n=27 (15.8%)

CUPIT ‘Impaired
Control’ – Mean (SD)

24.54 (9.15)

24.56 (9.17)

24.53 (9.16)

CUPIT ‘Problems’ –
Mean (SD)

3.03 (3.04)

3.30 (3.33)

2.77 (2.72)

BIS-11 – Mean (SD)

59.21 (11.60)

59.88 (10.87)

58.60 (12.25)

Ethnicity (%)

BIS-11, Barratt Impulsiveness Scale; CUPIT, The Cannabis Use Problems Identification Test; F, female; M, male; SD,
standard deviation.

40.00

the outcome variables (i.e. ‘Impaired Control’ and ‘Problems’)
on impulsivity, legalisation status, the interaction between
impulsivity and legalisation status, and a vector of control
variables. These models were found to explain 8% and 17% of
the variance in problematic cannabis use when using ‘Impaired
Control’ and ‘Problems’ subscales as the dependent variables,
respectively. Results from the regression models found that after
adjustment, impulsivity predicted ‘Impaired Control’ (β=0.24,
p=0.001) as well as ‘Problems’ (β=0.34, p<0.001). However, the
interaction between impulsivity and legalisation status was
not significant in both models suggesting that the relationship
between impulsivity and problematic cannabis use was not
different depending on legalisation status.

30.00

Discussion

Figure 2.

70.00

60.00

CUPIT and Barrat Impulsivity Scale
scores for both groups; cannabis legal
for recreational and/or medical purposes
and cannabis is prohibited.
Cannabis is illegal
Cannabis is legal for recreational
and/or medical use

Mean

50.00

20.00

10.00

0.00
CUPIT Problems
subscale

CUPIT Impaired Barratt Impulsiveness
Control subscale Scale (BIS-11)- Total
Score
Error Bars: 95% CI

cannabis use disorder; however, again there was no association
between state legalisation status and any of the three outcome
variables. Two linear multiple regression models (Table 2)
were then used to examine whether the relationship between
impulsivity and problematic cannabis use was moderated
by legalisation status. Specifically, these models regressed

These data indicate that there is a positive association between
problematic cannabis use and impulsivity in frequent cannabis
users. This finding is in accord with other studies showing
an association between problematic cannabis use and
impulsivity.9 A strong body of research shows that cannabis use
is linked with impulsivity, and studies suggest that impulsivity
is an important factor related to the early stages of addiction
processes, such as drug experimentation.10 Our results also
show that legalisation status in the USA is not associated with
problematic cannabis use and impulsivity. The current findings
go beyond prior studies to suggest that, at this point in time,
the legalisation status of cannabis has not shown an association
with cannabis use amongst frequent users, a finding supported
by a growing body of literature.6 Although the detrimental
health effects of frequent cannabis use are well established,3
our findings suggest that legalisation status does not worsen
these effects. It is too early to conclude that the legal status
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Table 2. Multiple regression analysis for variables predicting problematic cannabis use.
Variable

b

95% Confidence interval

BIS-11 total score

0.19

0.08; 0.30

0.001*

0.24

Legal vs Illegal

−0.95

−11.22; 9.32

0.86

−0.05

BIS-11 × Legalisation

0.01

−0.16; 0.18

0.90

0.04

Ethnicity

1.38

−1.16; 3.92

0.29

0.06

Age

0.08

−0.22; 0.38

0.60

0.03

Gender

−1.90

−3.89; 0.07

0.06

−0.10

R-squared

0.08

N

329

BIS-11 total score

0.09

0.06; 0.12

<0.001*

0.34

Legal vs Illegal

−1.14

−4.36; 2.09

0.49

−0.19

BIS-11 × Legalisation

0.03

−0.03; 0.08

0.36

0.26

Ethnicity

0.48

−0.31; 1.29

0.23

0.06

Age

−0.03

−0.12; 0.07

0.60

−0.03

Gender

−0.59

−1.21; 0.04

0.07

−0.10

R-squared

0.17

N

329

p-value

Standardised β

Regression 1: Impaired Control subscale as DV

Regression 2: CUPIT Problems subscale as DV

*p<0.05.
DV, dependent variable.

of cannabis in the USA has had no effects on problematic
cannabis use or cannabis-related harms, especially in states
with liberal definitions of cannabis use.2

Limitations of the study
Our study has several limitations. First, it uses cross-sectional
data, making it difficult to infer causality and establish whether
cannabis use is a cause, consequence, or correlate of altered
impulsivity. Future research would benefit from a longitudinal
design to track over the long term whether there is an association
between legalisation status of cannabis and problem use and
impulsivity. A second limitation is the small sample size, which
restricted our ability to investigate those using cannabis for
recreational purposes only compared with both recreational and
medical purposes. A third limitation is the recruitment design
that relied on online self-report data, which may lead to biases.
For instance, participants may not have reported their cannabis
use or impulsivity accurately due to memory impairments, which

are common in frequent cannabis users.12,13 Notwithstanding, all
participants were informed that their responses would remain
anonymous and confidential, encouraging genuine responses.
Furthermore, studies have reported that using self-reports are
relatively valid tools to measure cannabis use, even compared to
more objective measures such as urine tests.14,15 Nonetheless, it
should be noted that we cannot exclude the influence of biases
on the accuracy of this study’s results.

Conclusion
Despite the above limitations, our study supports the notion
that frequent cannabis use is associated with impulsive
behaviours, whilst, conversely, we did not find an association
between US state legalisation and problematic cannabis use
or impulsivity. These findings contribute to the debate related
to the benefits of legalising cannabis use and contribute to
the debate over the link between problematic cannabis use
and state legalisation status as well as impulsive behaviours.
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